CCR Monthly Approval Report – March 2023

A total of 17 products were added in the month from four different asset managers: WisdomTree, T. Rowe Price, Invesco, Capital Four, Equitix  and Madison Realty Capital.

This content is reserved for our licensees.

Log In Register

CCR loosens ratings requirements for cross-border-fund domiciles

The CCR lowered to A from AA the rating requirement on countries whose regulations are applicable to a fund or management company.

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – February 2023

A total of five products were added in the month from five different asset managers: AllianceBernstein, Credicorp Capital, HIG Capital, Q-Energy and TA Associates.

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – January 2023

Two ETFs, two mutual funds and one alternatives product gained CCR approval to kick off 2023. Sponsors gaining approval were Barings, GemCap, BNP Paribas, UBS and GlP.

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – December 2022

Ninety One and America Securities were the fund sponsors gaining approval for new products in December.

This content is reserved for our licensees.

Log In Register

CCR changes criteria and reinstates Allianz funds

In October 2022, Allianz was authorized to distribute 26 strategies to Chilean pension funds.

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – November 2022

A total of five products were added in the month from the following asset managers: Eastspring, Jupiter, Neuberger Berman, UBS and Stonepeak Partners. 

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – October 2022

A total of 35 products were added in the month from seven different asset managers: Aegon, Allianz, BNP Paribas, The Colchester, Bridge, Driftwood and Vitruvian.

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – September 2022

UBS, Altor and Cortland were the fund sponsors gaining approval for new products in September.

This content is reserved for our licensees.

Log In Register

CCR Monthly Approval Report – August 2022

A total of 15 products were added in the month from six different brands: Actis, Amundi, Brookfield, Global X, M&G, and Mirae.

This content is reserved for our licensees.

Log In Register